Raamdeo Agrawal, the billionaire investor known for his stock-picking expertise, has invested in Swiggy and Zepto, two leading companies in the quick-commerce sector that are preparing for their IPOs.
Amitabh Bachchan’s Family Office Joins the Investment
In addition to Agrawal, the family office of Bollywood superstar Amitabh Bachchan has also invested in Swiggy by acquiring shares from the company’s employees and early investors.
Swiggy Valued at $10-11 Billion
Although the exact investment amounts remain undisclosed, reports suggest that Swiggy is currently valued between $10-11 billion, reflecting its strong position in the quick-commerce market.
Zepto Secures Funding in Latest Round
Agrawal’s investment in Zepto came during the company’s recent $665 million funding round, further solidifying his confidence in the quick-commerce industry.
Agrawal’s Optimism for New-Age Businesses
Agrawal has recently expressed a bullish outlook on new-age businesses, highlighting the rapid growth potential of companies like Zomato, which are expanding at rates of 70-80% annually.
Motilal Oswal’s Strategic Moves in Zomato
While Agrawal remains optimistic, Motilal Oswal Mutual Fund has reduced its stake in Zomato following a sharp rally in the stock, though the firm continues to see a bright future for the industry.
Zomato’s Rising Stock and Future Potential
Motilal Oswal Financial Services maintains a “buy” rating on Zomato, with a target price of ₹300, citing Blinkit’s rapid growth and the disruptive nature of quick commerce as key drivers of future value.
A Promising Future for Quick Commerce
Agrawal’s investments in Swiggy and Zepto underscore his belief in the long-term potential of the quick-commerce sector, a market that continues to evolve and disrupt traditional industries.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.